Depression
Conditions
Brief summary
The study evaluate the effect of 10 neurofeedback sessions on the residual symptoms of depressive patients in partial remission.
Interventions
DEVICENeurofeedback sessions
10 Neurofeedback sessions, psychiatric interview (MADRS, QIDS-C16), reverse-correlation task, QIDS-SR16, EQ-5D-5L, motivation assessment
Sponsors
Centre Hospitalier Universitaire de Besancon
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Subjects aged 25 to 65 included * Information and signed informed consent * Patients with a diagnosis of major depressive episode in remission * MADRS score between 14 and 22 * Patients with residual symptoms as assessed by MADRS items * No cognitive impairment. * Right-handed
Exclusion criteria
* Subjects with legal incapacity or limited legal capacity * Subjects unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator * Pregnant women * Subjects in the exclusion period of another study or is on the national volunteer list. * Subjects with another psychiatric pathology (bipolar mood disorder, psychosis, obsessive-compulsive disorder, addictive pathology, schizophrenia) * Subjects under a protective measure such as guardianship or safeguard of justice.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Evaluate the effect of 10 neurofeedback sessions on residual symptoms in depressive patients in partial remission | Week 10 | Reduction in MADRS score to \< 8 (complete remission) after 10 neurofeedback sessions, in particular cumulative score less than or equal to 2 for hedonic and fatigue dimensions |
Countries
France
Contacts
Primary ContactKarine CHARRIERE, PhD
Outcome results
None listed